pyridinolcarbamate has been researched along with Bradycardia in 1 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
Bradycardia: Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, I | 1 |
| Didisheim, P | 1 |
1 other study available for pyridinolcarbamate and Bradycardia
| Article | Year |
|---|---|
Systemic effects of ADP-induced platelet aggregation and their modification by aspirin and by pyridinolcarbamate.
Topics: Adenosine Diphosphate; Animals; Arrhythmias, Cardiac; Aspirin; Blood Cell Count; Blood Platelets; Br | 1973 |